Array Biopharma (NASDAQ:ARRY) reported earnings of ($0.05) per share beating Walls Streets expectations.

ME Staff
-
0

Array Biopharma (NASDAQ:ARRY) reported 12/31/2018 earnings this Morning, coming in at ($0.05) per share, beating Wall Street’s estimates of ($0.16) per Share. Revenue for the quarter came in at $82.55 million beating analyst estimates of $52.44 million

      Recent Trading for Array Biopharma (NASDAQ:ARRY)
      Shares of Array Biopharma closed the previous trading session at with 19.91 shares trading hands.